LCTX icon

Lineage Cell Therapeutics

106 hedge funds and large institutions have $130M invested in Lineage Cell Therapeutics in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

1% less funds holding

Funds holding: 107106 (-1)

9% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 11

Holders
106
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$215K
Puts
$78K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$70.4M
2
$14.3M
3
$10.5M
4
$5.44M
5
$4.94M
6
$4.35M
7
$2.8M
8
$2.34M
9
$1.98M
10
$1.8M
11
$1.24M
12
$837K
13
$559K
14
$482K
15
$469K
16
$448K
17
$436K
18
$386K
19
$368K
20
$340K
21
$322K
22
$276K
23
$235K
24
$234K
25
$233K